Novo Nordisk | NVO - مصاريف البيع والإدارة





مصاريف البيع والإدارة تغيير تاريخ
ANI Pharmaceuticals USD 91.66M 18.01M 2026-06
Aurora Cannabis CAD 41.4M 781K 2026-03
Bausch Health Companies USD 901M 88M 2026-06
Bristol-Myers Squibb USD 1.83B 209M 2026-06
Canopy Growth CAD 31.17M 2.27M 2026-03
Corcept Therapeutics USD 156.9M 28.85M 2026-06
Drreddys Laboratories INR 14.47B 12.45B 2026-03
Eli Lilly USD 3.43B 496M 2026-06
GlaxoSmithKline GBP 2.19B 75M 2026-06
Merck USD 2.89B 219M 2026-06
Nektar Therapeutics USD 11.87M 1.7M 2026-03
Novartis USD 3.24B 101M 2026-06
Novo Nordisk DKK 16.31B 3.09B 2026-06
Novo Nordisk DKK 2.54B 10.68B 2026-06
Pacira USD 91.81M 7.93M 2026-06
Perrigo USD 3.28B 3.02B 2026-06
Phibro Animal Health USD 78.32M 10.24M 2025-12
Prestige Brands USD 43.3M 13.02M 2026-06
Sanofi EUR 2.63B 307M 2026-06
Supernus Pharmaceuticals USD 133.64M 15.41M 2026-06
Zoetis USD 592M 4M 2026-06